AA |
arachidonic acid |
ACE |
angiotensin-converting enzyme |
ACEi |
angiotensin-converting enzyme inhibitor |
ACE2 |
angiotensin-converting enzyme type 2 |
ACF |
aorto-caval fistula |
ANG II |
angiotensin II |
ANG 1-7 |
angiotensin 1-7 |
AT1A |
angiotensin II type 1 receptor subtype A |
AT2 |
angiotensin II type 2 receptor |
CKD |
chronic kidney disease |
CYP |
cytochrome P-450 enzyme |
CYP2C23 |
cytochrome P-450 enzyme subfamily 2C23 |
CYP4A1 |
cytochrome P-450 enzyme subfamily 4A1 |
(+dP/dt)max |
maximum rates of pressure rise |
(−dP/dt)max |
maximum rates of pressure fall |
DHETEs |
dihydroxyeicosatrienoic acids |
EET-A |
14,15-epoxyeicosatrienoic acid analog |
EETs |
epoxyeicosatrienoic acids |
EDPVR |
end-diastolic pressure-volume relationship |
ESPVR |
end-systolic pressure-volume relationship |
FHH |
fawn-hooded hypertensive rats |
FHL |
fawn-hooded low-pressure rats |
GFR |
glomerular filtration rate |
HanSD |
normotensive, transgene-negative, Hannover Sprague-Dawley rats |
HF |
heart failure |
IKEM |
Institute for Clinical and Experimental Medicine |
LV |
left ventricle |
MAP |
mean arterial pressure |
mRNA |
messenger ribonucleic acid |
NE |
norepinephrine |
PRSW |
preload recruitable stroke work |
RAS |
renin-angiotensin system |
RBF |
renal blood flow |
RDN |
renal denervation |
RSNA |
renal sympathetic nerve activity |
RV |
right ventricle |
sEH |
soluble epoxide hydrolase |
SHR |
spontaneously hypertensive rats |
TGR |
Ren2 renin transgenic, hypertensive rats |
TPR |
total peripheral resistance |
20-HETE |
20-hydroxyeicosatrienoic acid |